Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 15 full-time employees. The company went IPO on 2018-02-14. The company has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.
Follow-Up Questions
Motus GI Holdings Inc (MOTS)의 PER은 얼마입니까?
Motus GI Holdings Inc의 PER은 0입니다
Motus GI Holdings Inc의 CEO는 누구입니까?
Mr. Mark Pomeranz은 2016부터 회사에 합류한 Motus GI Holdings Inc의 President입니다.
MOTS 주식의 가격 성능은 어떻습니까?
MOTS의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Motus GI Holdings Inc의 주요 사업 주제나 업종은 무엇입니까?
Motus GI Holdings Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Motus GI Holdings Inc의 시가총액은 얼마입니까?
Motus GI Holdings Inc의 현재 시가총액은 $6.39입니다
Motus GI Holdings Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Motus GI Holdings Inc에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 4명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다